MARKET

BIOL

BIOL

BIOLASE
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.2921
-0.0110
-3.63%
After Hours: 0.2910 -0.0011 -0.38% 19:59 10/20 EDT
OPEN
0.3005
PREV CLOSE
0.3031
HIGH
0.3066
LOW
0.2907
VOLUME
1.09M
TURNOVER
--
52 WEEK HIGH
0.9600
52 WEEK LOW
0.2110
MARKET CAP
26.93M
P/E (TTM)
-0.4222
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Why Biolase's Stock Is Trading Higher Today
Biolase (NASDAQ: BIOL) shares are trading higher on Wednesday after the company issued third-quarter sales guidance above analyst estimates.
Benzinga · 6d ago
BIOLASE Announces Preliminary Third Quarter Revenue Results; Reopening Of Dental Practices Drives Sequential Revenue Growth
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced unaudited preliminary revenue results for the third quarter ended September 30, 2020. The Company expects to report third quarter revenue in the range of $6.4 million to $6.6 million, a significant sequential improvement from the 2020 second quarter. Additionally, the Company's U.S. revenue is anticipated to be in-line with its third quarter 2019 U.S. results (pre-COVID-19), as dentists continued to resume normal business practices, while Waterlase sales to new customers accounted for more than 90% of the Company's total U.S. laser revenue during the third quarter of 2020.
PR Newswire · 6d ago
Here's Why You Should Hold on to Stryker (SYK) Stock Now
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.
Zacks · 10/13 09:42
Ecolab Introduces New Automated Precision Dispensing System
Ecolab's (ECL) newly launched Precision Dispensing System for Membranes can drive productivity and boost worker safety.
Zacks · 10/09 11:36
Masimo Unveils New Wearable Wireless Continuous Thermometer
Masimo's (MASI) wearable wireless continuous thermometer offers consumers hassle-free continuous body temperature measurements, thereby eliminating the need for manual measurements.
Zacks · 10/08 15:17
Here's Why You Should Retain Fresenius Medical Stock Now
Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services. However, intense competition remains a woe.
Zacks · 10/06 14:14
BD Gets 510(k) Clearance for Its FACSLyric Flow Cytometer
BD (BDX) gets 510(k) clearance from the FDA for its new integrated system that helps clinical laboratories to fully automate the sample to answer process and boost their efficiency.
Zacks · 10/06 14:12
BIOLASE To Host Expert Panel Webinar On The Advantages Of Using Laser Dentistry In The Current Healthcare Environment; Dental Practices Resuming Normal Operations As Procedure Volumes Reach 70% Of Pre-COVID Levels
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will host an investor and analyst webinar on Wednesday, Oct. 14, 2020, at 1:00 pm ET, with a panel of leading dental experts to discuss the advantages of utilizing laser dentistry and its ability to mitigate the
PR Newswire · 10/05 12:30
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BIOL. Analyze the recent business situations of BIOLASE through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BIOL stock price target is 1.475 with a high estimate of 2.000 and a low estimate of 1.000.
EPS
Institutional Holdings
Institutions: 41
Institutional Holdings: 5.59M
% Owned: 6.07%
Shares Outstanding: 92.19M
TypeInstitutionsShares
Increased
8
545.54K
New
10
-3.65M
Decreased
4
3.49M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.48%
Healthcare Equipment & Supplies
-0.72%
Key Executives
Chairman/Independent Director
Jonathan Lord
President/Chief Executive Officer/Director
Todd Norbe
Chief Financial Officer/Executive Vice President
John Beaver
Vice President - Operations
Richard Whipp
Independent Director
Michael DiTolla
Independent Director
Richard Lanman
Independent Director
Jess Roper
Independent Director
Garrett Sato
Independent Director
Elaine Wagner
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 0.01
06/24/2005
--
Dividend USD 0.01
04/21/2005
--
Dividend USD 0.01
02/08/2005
--
Dividend USD 0.01
12/13/2004
--
Dividend USD 0.01
10/08/2004
07/27/2004
Dividend USD 0.01
08/12/2004
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About BIOL
BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of BIOLASE Inc stock information, including NASDAQ:BIOL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIOL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BIOL stock methods without spending real money on the virtual paper trading platform.